Migraines and cluster headaches can have devastating consequences on people’s lives, and there is a need to educate the public about the impact these disorders can have, said Abraham Nagy, MD, chair of neurology at University of Las Vegas and director of Nevada Headache Institute.
Migraines and cluster headaches can have devastating consequences on people’s lives, and there is a need to educate the public about the impact these disorders can have, said Abraham Nagy, MD, chair of neurology at University of Las Vegas and director of Nevada Headache Institute.
Transcript
There are many types of headache—how much education is needed to help patients understand what type of headache they have and what the best treatment might be?
So, there are many, many kinds of headache disorders out there and I think one of the biggest illnesses that we have as clinicians is educating our own clinicians about headache types and that’s one of the big important aspects of the American Academy of Neurologist. We, as neurologists, become ambassadors for headache disorders to other care providers, and it would be wonderful if we can then have our other care providers help provide a baseline education.
It’s a very big limitation, but I think that migraine disorders and cluster headache disorders are becoming more understood by the public as neurologic disabilities that can have devastating consequences in people’s lives. For a very long time, headache disorders were thought of as nonconsequential events that could just be treated with a minimal line of care or something over the counter.
But now we’re realizing quite a lot more that this is, there’s a significant disability associated with these events, and we’re trying to make strides in educating the population about this.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen